Hillard M. Lazarus

机构：University Hospitals of Cleveland, Acceleron Pharma (United States), GLC Biotechnology (United States), Case Western Reserve University · ORCID：0000-0002-1159-5607

发表论文 1046 篇 · 总被引 51249 次 · h-index 111

代表论文

Protein Biomarkers in Monocytes and CD4+ Lymphocytes for Predicting Lithium Treatment Response of Bipolar Disorder: a Feasibility Study with Tyramine-Based Signal- Amplified Flow Cytometry (2025 · Psychopharmacology Bulletin · 被引 17)
Endogenous and exogenous cytokines: An overview and introduction (2025 · Best Practice & Research Clinical Haematology · 被引 5)
Intensive post-remission therapy does not decrease relapse after allotransplants for acute myeloid leukaemia in 1st remission and should not be given (2025 · Leukemia · 被引 4)
Neuro-toxicities of chemo- and immune-therapies in haematologic malignancies: from mechanism to management (2024 · Blood Reviews · 被引 4)
Genomic determinants of treatment outcome and identification of a new genomic subset of adult acute lymphoblastic leukemia from the ECOG-ACRIN E1910 randomized phase III trial (2025 · Blood · 被引 2)
Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults (2025 · Blood Advances · 被引 2)